During the past decade, Kaiser Permanente - Towson Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Towson Medical Center" #1 sponsor was "ETOP IBCSG Partners Foundation" with 1 trials, followed by "Eastern Cooperative Oncology Group" with 1 trials sponsored, "GOG Foundation" with 1 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored and "National Cancer Institute (NCI)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Towson Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NCIC Clinical Trials Group" with 1 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Towson Medical Center" are "Breast Cancer" (1 trials), "Estrogen Receptor Positive Breast Cancer" (1 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (1 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (1 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (1 trials). Many other conditions were trialed in "Kaiser Permanente - Towson Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Towson Medical Center" are "Drug" (4 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (3 trials), "Quality-of-Life Assessment" (3 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Towson Medical Center" are 4 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Towson Medical Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kaiser Permanente - Towson Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Towson Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".